Tag Archive for: PARP inhibitor
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
177Lu-PSMA-617 225Ac abiraterone abiraterone acetate ADC ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T CD3 clinical trial crispr darolutamide docetaxel drug repurposing enzalutamide EZH2 inhibitor HRR immunotherapy mcrpc metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer oncolytic virus PARP1 PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data STEAP1 T-cell therapy
Latest Posts
- UPDATE: Phase 3 Pivotal Trial for 177Lu-NYM032 September 1, 2026
- Beyond CRISPR? TIGRa: The Tiny Genetic Switch That Could Let the Body Heal Itself September 1, 2026
- Newsletter 35/2026 August 30, 2026
- Soon to Be Phase 1: ADI‑212 Off The Shelf CAR T Therapy for mCRPC August 28, 2026